XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS—(UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income $ 39,111 $ 54,749
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for credit losses 35,800 14,182
Depreciation on premises and equipment 3,721 3,567
Amortization of intangible assets 3,056 3,628
Amortization of operating lease right-of-use asset 1,219 1,241
Amortization of loan servicing rights 1,925 861
Share-based compensation expense 2,139 1,796
Increase in cash surrender value of life insurance (5,708) (2,685)
Investment securities accretion, net (3,741) (1,424)
Loss on sales of investment securities, net 196 6,478
Gain on repurchase of subordinated debt (244) (676)
Gain on sales of other real estate owned (22) (819)
Impairment on other real estate owned 1,278 0
Origination of loans held for sale (55,951) (45,690)
Proceeds from sales of loans and leases held for sale 67,614 65,291
Gain on sale of loans held for sale (1,716) (1,712)
Net change in operating assets and liabilities:    
Accrued interest receivable (2,165) (3,970)
Other assets 5,203 (58,408)
Accrued expenses and other liabilities (13,501) 30,874
Net cash provided by operating activities 78,214 67,283
Cash flows from investing activities:    
Purchases of investment securities available for sale (471,040) (305,021)
Proceeds from sales of investment securities available for sale 58,874 165,871
Maturities and payments on investment securities available for sale 140,682 43,838
Purchases of equity securities (214) (244)
Proceeds from sales of equity securities 0 5,148
Net decrease (increase) in loans 348,351 (6,195)
Purchases of premises and equipment (4,185) (7,064)
Proceeds from sale of premises and equipment 0 104
Purchases of nonmarketable equity securities (169,806) (157,382)
Proceeds from redemptions of nonmarketable equity securities 172,057 158,372
Proceeds from sales of other real estate owned 301 7,346
Purchases of company-owned life insurance, net 0 (48,622)
Net cash provided by (used in) investing activities 75,020 (143,849)
Cash flows from financing activities:    
Net (decrease) increase in deposits (52,693) 40,350
Net decrease in short-term borrowings (21,016) (24,313)
Net decrease in short-term FHLB borrowings (46,000) (27,000)
Proceeds from long-term FHLB borrowings 255,000 130,000
Payments made on long-term FHLB borrowings (260,000) (25,000)
Payments made on subordinated debt (10,756) (5,845)
Cash dividends paid on preferred stock (6,685) (6,685)
Cash dividends paid on common stock (20,283) (20,008)
Common stock repurchased (5,504) (15,025)
Proceeds from issuance of common stock under employee benefit plans 1,515 1,593
Net cash (used in) provided by financing activities (166,422) 48,067
Net decrease in cash and cash equivalents (13,188) (28,499)
Cash and cash equivalents:    
Beginning of period 135,061 160,631
End of period 121,873 132,132
Supplemental disclosures of cash flow information:    
Interest paid on deposits and borrowed funds 144,205 114,011
Income tax paid (net of refunds) 21,870 17,762
Supplemental disclosures of noncash investing and financing activities:    
Transfer of loans to other real estate owned 982 278
Right of use assets obtained in exchange for lease obligations 2,707 2,459
Transfer of loan servicing rights held for sale to loan servicing rights, at lower of cost or market $ 0 $ 20,745